Cargando…
Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K(V)10.1 Pore Blockers
The K(V)10.1 voltage-gated potassium channel is highly expressed in 70% of tumors, and thus represents a promising target for anticancer drug discovery. However, only a few ligands are known to inhibit K(V)10.1, and almost all also inhibit the very similar cardiac hERG channel, which can lead to und...
Autores principales: | Toplak, Žan, Merzel, Franci, Pardo, Luis A., Peterlin Mašič, Lucija, Tomašič, Tihomir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396485/ https://www.ncbi.nlm.nih.gov/pubmed/34445705 http://dx.doi.org/10.3390/ijms22168999 |
Ejemplares similares
-
3D Pharmacophore-Based Discovery of Novel K(V)10.1 Inhibitors with Antiproliferative Activity
por: Toplak, Žan, et al.
Publicado: (2021) -
New Diarylamine K(V)10.1 Inhibitors and Their Anticancer Potential
por: Gubič, Špela, et al.
Publicado: (2022) -
Efficient Synthesis of Hydroxy-Substituted 2-Aminobenzo[d]thiazole-6-carboxylic Acid Derivatives as New Building
Blocks in Drug Discovery
por: Durcik, Martina, et al.
Publicado: (2020) -
Discovery of K(V)1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges
por: Gubič, Špela, et al.
Publicado: (2021) -
Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors
por: Dernovšek, Jaka, et al.
Publicado: (2021)